Search

everythinglearnresearchcommunity

for

Search:↓

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Women with PCOS have higher cardiometabolic risks.

Individualized treatment improves symptoms and quality of life for women with PCOS.

Certain gene variations may increase the risk of PCOS in South Indian women.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

A woman's hair loss condition got worse after her varicose vein treatment with a specific foam.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Early hair loss may indicate risk of insulin resistance.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.